PapersPMID:34178867
The effect of spirulina on type 2 diabetes: a systematic review and meta-analysis.
- findings
- 3
- compound
- 1
- endpoints
- 3
- no difference found
- 1
- Study, every finding
- meta-analysis
- Population, every finding
- Patients with type 2 diabetes; eight studies (9 arms) pooled, random effects
What moved
How to read these marks →“We found a significant reduction in fasting blood glucose (-17.88 mg/dl; 95% CI: -26.99, -8.78; I 2 : 25%), triglyceride (-30.99 mg/dl; 95% CI: -45.20, -16.77; I 2 : 50%), total-cholesterol (-18.47 mg/dl; 95% CI: -33.54, -3.39; I 2 : 73%), LDL-C (-20.04 mg/dl; 95% CI: -34.06, -6.02; I 2 : 75%), VLDL (-6.96 mg/dl; 95% CI: -9.71, -4.22; I 2 : 33%), in addition to a significant increase in HDL-C (-6.96 mg/dl; 95% CI: -9.71, -4.22; I 2 : 33%), after spirulina administration.”
- Decreases fasting blood glucose
very limited
- Effect
- −17.88 mean difference, 95% CI −26.99 to −8.78
- Decreases triglycerides
very limitedreplicated ×4
- Effect
- −30.99 mean difference, 95% CI −45.2 to −16.77
What did not
“No significant effect was observed on HbA1C or post prandial blood sugar following spirulina consumption.”
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Type 2 diabetes patients
- Participants
- not reported
- Comparator
- not stated in the paper
- Duration
- not reported
- Endpoints measured
- 8